NL-OMON38943已完成不适用
Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Escalating Doses of Intravenous WCK 4282 in Healthy Adult Human Subjects - WCK 4282 MAD Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •18 - 65 years inclusive
- •BMI 18.0 - 30.0 kg/m2 inclusive
- •non-smoker
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS.
- •Participation in another drug study within 60 days prior to randomization.
- •Any donation of blood(products) or significant blood loss within 60 days prior to drug administration
研究者
相似试验
进行中（未招募）
1 期
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer TreatmentAttention impairment after cancer treatmentEUCTR2007-005435-28-GBEisai Limited71
进行中（未招募）
不适用
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer TreatmentEUCTR2007-005435-28-NLEisai Limited300
进行中（未招募）
不适用
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer TreatmentAttention impairment after cancer treatmentEUCTR2007-005442-20-BEEisai Limited70
进行中（未招募）
1 期
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer TreatmentAttention impairment after cancer treatmentEUCTR2007-005435-28-FREisai Limited71
进行中（未招募）
1 期
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children with Attention Impairment Following Cancer Treatment Estudio aleatorizado, doble ciego, controlado con placebo sobre la eficacia y seguridad del clorhidrato de donepezilo en niños preadolescentes y adolescentes con trastorno de atención después del tratamiento para el cáncerEUCTR2007-005442-20-ESEisai Limited300